CAS 195875-84-4
:Tesofensine
Description:
Tesofensine is a chemical compound that functions primarily as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). It was originally developed for the treatment of neurodegenerative diseases but has gained attention for its potential use in weight management and obesity treatment. Tesofensine is characterized by its ability to modulate neurotransmitter levels, which can lead to appetite suppression and increased energy expenditure. The compound is typically administered in oral form and has been studied for its pharmacokinetics, showing a relatively short half-life. Its mechanism of action involves the inhibition of the reuptake of key neurotransmitters, enhancing their availability in the synaptic cleft. Tesofensine has demonstrated efficacy in clinical trials, leading to significant weight loss in participants. However, like many pharmacological agents, it may be associated with side effects, including cardiovascular effects and potential impacts on mood. As research continues, the safety and long-term effects of Tesofensine are important considerations for its therapeutic use.
Formula:C17H23Cl2NO
InChI:InChI=1S/C17H23Cl2NO/c1-3-21-10-14-13(9-12-5-7-17(14)20(12)2)11-4-6-15(18)16(19)8-11/h4,6,8,12-14,17H,3,5,7,9-10H2,1-2H3/t12-,13+,14+,17+/m0/s1
InChI key:InChIKey=VCVWXKKWDOJNIT-ZOMKSWQUSA-N
SMILES:C(OCC)[C@@H]1[C@H](C[C@]2(N(C)[C@@]1(CC2)[H])[H])C3=CC(Cl)=C(Cl)C=C3
Synonyms:- NS 2330
- 8-Azabicyclo[3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, [1R-(2-endo,3-exo)]-
- 8-Azabicyclo[3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, (1R,2R,3S,5S)-
- Tesofensine
- (1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Tesofensine
CAS:Controlled Product<p>Applications Tesofensine, is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is currently in clinical development for the treatment of obesity.<br>References Hansen, H., et al.: Pharmacology, Biochemistry and Behavior, 110, 265 (2013);<br></p>Formula:C17H23Cl2NOColor and Shape:NeatMolecular weight:328.28Tesofensine-d5
CAS:Controlled ProductFormula:C17D5H18Cl2NOColor and Shape:NeatMolecular weight:333.307Tesofensine
CAS:Tesofensine, a serotonin–noradrenaline–dopamine reuptake inhibitor, is used potentially for the treatment of obesity.Formula:C17H23Cl2NOPurity:98%Color and Shape:SolidMolecular weight:328.28



